- Home
- LEGN vs RLI Comparison
LEGN vs RLI Comparison
Compare LEGN & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- RLI
- Stock Information
- Founded
- LEGN 2014
- RLI 1965
- Country
- LEGN United States
- RLI United States
- Employees
- LEGN N/A
- RLI N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- RLI Property-Casualty Insurers
- Sector
- LEGN Health Care
- RLI Finance
- Exchange
- LEGN Nasdaq
- RLI Nasdaq
- Market Cap
- LEGN 7.0B
- RLI 7.1B
- IPO Year
- LEGN 2020
- RLI 1985
- Fundamental
- Price
- LEGN $32.38
- RLI $74.83
- Analyst Decision
- LEGN Strong Buy
- RLI Hold
- Analyst Count
- LEGN 13
- RLI 8
- Target Price
- LEGN $79.42
- RLI $78.60
- AVG Volume (30 Days)
- LEGN 1.5M
- RLI 399.8K
- Earning Date
- LEGN 05-13-2025
- RLI 04-23-2025
- Dividend Yield
- LEGN N/A
- RLI 6.71%
- EPS Growth
- LEGN N/A
- RLI N/A
- EPS
- LEGN N/A
- RLI 3.03
- Revenue
- LEGN $627,241,000.00
- RLI $1,733,218,000.00
- Revenue This Year
- LEGN $65.96
- RLI N/A
- Revenue Next Year
- LEGN $52.55
- RLI $4.70
- P/E Ratio
- LEGN N/A
- RLI $24.68
- Revenue Growth
- LEGN 119.97
- RLI 8.88
- 52 Week Low
- LEGN $29.27
- RLI $68.50
- 52 Week High
- LEGN $60.87
- RLI $91.15
- Technical
- Relative Strength Index (RSI)
- LEGN 45.13
- RLI 45.47
- Support Level
- LEGN $30.25
- RLI $73.82
- Resistance Level
- LEGN $35.81
- RLI $75.22
- Average True Range (ATR)
- LEGN 1.43
- RLI 1.54
- MACD
- LEGN -0.14
- RLI -0.01
- Stochastic Oscillator
- LEGN 38.36
- RLI 34.32
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.